APOE Gene Lipoprotein Glomerulopathy Genetic Test
At DNA Labs UAE, we offer the APOE Gene Lipoprotein Glomerulopathy Genetic Test to help diagnose and manage this rare kidney disorder. Read on to learn more about the test, including its cost, symptoms, and diagnosis process.
Test Details
The APOE gene is responsible for encoding a protein called apolipoprotein E, which plays a crucial role in lipid metabolism and transport. Mutations in the APOE gene can lead to various disorders, including lipoprotein glomerulopathy.
Lipoprotein glomerulopathy is a rare kidney disorder characterized by the accumulation of abnormal lipoproteins in the glomeruli, which are the filtering units of the kidneys. This buildup can lead to kidney damage and eventually kidney failure.
NGS (Next-Generation Sequencing) genetic testing is a method used to analyze the DNA sequence of genes, including the APOE gene. This type of testing can identify mutations or variations in the APOE gene that may be associated with lipoprotein glomerulopathy.
NGS testing allows for a comprehensive analysis of multiple genes simultaneously, providing a more efficient and cost-effective approach compared to traditional sequencing methods. By identifying genetic mutations in the APOE gene through NGS testing, healthcare professionals can make an accurate diagnosis of lipoprotein glomerulopathy and provide appropriate management and treatment strategies for affected individuals.
Test Name
APOE Gene Lipoprotein Glomerulopathy Genetic Test
Components
- Price: 4400.0 AED
- Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
- Report Delivery: 3 to 4 Weeks
- Method: NGS Technology
- Test Type: Hepatology Nephrology Endocrinology Disorders
- Doctor: General Physician
- Test Department: Genetics
Pre Test Information
Clinical History of Patient who is going for APOE Gene Lipoprotein Glomerulopathy NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with APOE Gene Lipoprotein Glomerulopathy NGS Genetic DNA Test gene APOE.
It is important to gather the clinical history of the patient before conducting the APOE Gene Lipoprotein Glomerulopathy Genetic Test. Additionally, a genetic counseling session may be conducted to draw a pedigree chart of family members affected by the APOE Gene Lipoprotein Glomerulopathy NGS Genetic DNA Test gene APOE.
Conclusion
The APOE Gene Lipoprotein Glomerulopathy Genetic Test offered by DNA Labs UAE is a valuable tool in diagnosing and managing lipoprotein glomerulopathy. With its use of NGS technology, this test provides a comprehensive analysis of the APOE gene and can help healthcare professionals make accurate diagnoses and treatment decisions. If you suspect you or a loved one may have lipoprotein glomerulopathy, consider getting tested today.
| Test Name | APOE Gene Lipoprotein glomerulopathy Genetic Test |
|---|---|
| Components | |
| Price | 4400.0 AED |
| Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card |
| Report Delivery | 3 to 4 Weeks |
| Method | NGS Technology |
| Test type | Hepatology Nephrology Endocrinology Disorders |
| Doctor | General Physician |
| Test Department: | Genetics |
| Pre Test Information | Clinical History of Patient who is going for APOE Gene Lipoprotein glomerulopathy NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with APOE Gene Lipoprotein glomerulopathy NGS Genetic DNA Test gene APOE |
| Test Details |
The APOE gene is responsible for encoding a protein called apolipoprotein E, which plays a crucial role in lipid metabolism and transport. Mutations in the APOE gene can lead to various disorders, including lipoprotein glomerulopathy. Lipoprotein glomerulopathy is a rare kidney disorder characterized by the accumulation of abnormal lipoproteins in the glomeruli, which are the filtering units of the kidneys. This buildup can lead to kidney damage and eventually kidney failure. NGS (Next-Generation Sequencing) genetic testing is a method used to analyze the DNA sequence of genes, including the APOE gene. This type of testing can identify mutations or variations in the APOE gene that may be associated with lipoprotein glomerulopathy. NGS testing allows for a comprehensive analysis of multiple genes simultaneously, providing a more efficient and cost-effective approach compared to traditional sequencing methods. By identifying genetic mutations in the APOE gene through NGS testing, healthcare professionals can make an accurate diagnosis of lipoprotein glomerulopathy and provide appropriate management and treatment strategies for affected individuals. |
